A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? https://t.co/JRrgLzt3IB
RT @Oncotarget: The cover for issue 38 of @Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from…
RT @Oncotarget: The cover for issue 38 of @Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from…
RT @Oncotarget: The cover for issue 38 of @Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from…
RT @Oncotarget: The cover for issue 38 of @Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from…
RT @errykkatayama: A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? @JordanMWinterMD @jj_hu…
The cover for issue 38 of @Oncotarget features Figure 3, "Summary of the time and cost for drug development (modified from DiMasi et al [2016]," by Katayama, et al. https://t.co/7cRVnJ7mC1
RT @errykkatayama: A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? @JordanMWinterMD @jj_hu…
RT @errykkatayama: A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? @JordanMWinterMD @jj_hu…
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike? @JordanMWinterMD @jj_hue @TheNotoriousHPB @dlbajor @AmmoriJohn and Dr. Jeffrey Hardacre @winterlab8 We must push forward and discover the cure to PC! https: